Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187563 · ClinicalTrials.gov registry record
A Study of Tocilizumab in Patients With Rheumatoid Arthritis
A clinical trial, sponsored by Regeneron Pharmaceuticals.
- Completed
- Registry status
- 16
- Enrollment target
NCT01187563 is a clinical trial that has completed, run by Regeneron Pharmaceuticals. The registered enrollment target is 16 participants.
The verdict
NCT01187563 has completed, sponsored by Regeneron Pharmaceuticals.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This is an open-label, uncontrolled, observational study in patients with rheumatoid arthritis (RA) who are receiving tocilizumab concomitantly with methotrexate as part of their standard of care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01187563
The ClinicalTrials.gov registry entry for NCT01187563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regeneron Pharmaceuticals, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01187563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01187563 about?
NCT01187563 is a clinical study titled "A Study of Tocilizumab in Patients With Rheumatoid Arthritis". This is an open-label, uncontrolled, observational study in patients with rheumatoid arthritis (RA) who are receiving tocilizumab concomitantly with methotrexate as part of their standard of care.
What is the current status of trial NCT01187563?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2010-08. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01187563?
This trial is sponsored by Regeneron Pharmaceuticals, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.